NASDAQ:FENC
Fennec Pharmaceuticals Inc.
- Stock
Last Close
9.75
13/05 20:00
Market Cap
263.68M
Beta: 0.16
Volume Today
126.32K
Avg: 80.91K
PE Ratio
−11.72
PFCF: −16.43
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.01 - | 0.06 - | 0.81 1,321.09% | |||||||||
cash conversion cycle | -7.33K - | -317.46 95.67% | ||||||||||
cash per share | 0.17 - | 0.23 36.59% | 0.09 62.77% | 0.31 253.50% | 1.88 511.99% | 1.20 36.35% | 0.68 42.92% | 1.28 87.20% | 0.81 36.62% | 0.90 11.52% | 0.50 45.10% | |
company equity multiplier | -1.20 - | 3.87 421.35% | 1.86 51.94% | 1.11 40.17% | 1.06 4.60% | 1.08 1.45% | 1.19 10.63% | 1.08 9.28% | 1.42 31.50% | -10.49 837.88% | -2.31 77.96% | |
days of inventory outstanding | 2.44K - | 610.66 75.02% | ||||||||||
days of payables outstanding | 10.14K - | 1.08K 89.39% | ||||||||||
days of sales outstanding | 367.38 - | 147.89 59.74% | ||||||||||
dividend yield | ||||||||||||
ebit per revenue | -105.21 - | -14.72 - | -0.60 95.92% | |||||||||
ebt per ebit | -0.96 - | 0.76 179.16% | 0.35 53.90% | 0.97 178.61% | 1.01 4.35% | 0.95 6.29% | 0.98 3.38% | 1.01 3.11% | 1.01 0.53% | 1.05 4.24% | 1.26 19.68% | |
effective tax rate | -0.00 - | 0.00 184.79% | 0.00 395.30% | 0.00 36.99% | 0.01 132.55% | 0.04 427.61% | 0.02 29.94% | 0.01 58.12% | -0.01 161.41% | -0.05 648.09% | -0.00 100.00% | |
enterprise value multiple | -14.68 - | -6.78 53.82% | -5.75 15.13% | -7.90 37.26% | -17.92 126.91% | -9.32 48.02% | -8.91 4.38% | -8.13 8.72% | -5.72 29.65% | -11.24 96.46% | -24.18 115.18% | |
fixed asset turnover | ||||||||||||
free cash flow per share | -0.23 - | -0.17 24.31% | -0.17 0.08% | -0.17 3.25% | -0.24 45.74% | -0.41 69.71% | -0.45 10.28% | -0.66 44.95% | -0.55 16.88% | -0.69 25.67% | ||
gross profit margin | 1 - | 0.94 - | 0.94 0.34% | |||||||||
interest coverage | -1.44K - | -136.69 - | -23.10 83.10% | -3.47 84.98% | ||||||||
inventory turnover | 0.15 - | 0.60 300.33% | ||||||||||
long term debt to capitalization | 0.24 - | 1.12 364.08% | 1.64 47.29% | |||||||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.98 2.47% | 0.99 1.47% | 1.01 1.68% | 1.05 4.08% | 1 4.53% | |
net profit margin | -105.42 - | -16.18 - | -0.75 95.33% | |||||||||
operating cash flow per share | -0.23 - | -0.17 24.31% | -0.17 0.08% | -0.17 3.25% | -0.24 45.74% | -0.41 69.71% | -0.45 10.28% | -0.66 44.95% | -0.55 16.88% | -0.69 25.67% | ||
operating cycle | 2.81K - | 758.55 73.02% | ||||||||||
operating profit margin | -105.21 - | -14.72 - | -0.60 95.92% | |||||||||
payables turnover | 0.04 - | 0.34 842.70% | ||||||||||
pretax profit margin | -106.52 - | -15.45 - | -0.75 95.11% | |||||||||
price fair value | -20.64 - | 43.32 309.86% | 34.46 20.44% | 7.65 77.81% | 5.62 26.47% | 5.69 1.24% | 10.91 91.65% | 6.07 44.31% | 7.26 19.43% | -98.19 1,453.35% | -25.79 73.74% | |
receivables turnover | 0.99 - | 2.47 148.41% | ||||||||||
return on assets | 1.05 - | -0.92 187.11% | -0.65 29.50% | -0.70 8.57% | -0.25 64.67% | -0.43 73.67% | -0.88 104.44% | -0.57 35.24% | -0.78 36.52% | -0.92 18.39% | -0.61 33.70% | |
return on capital employed | 1.33 - | -4.69 453.64% | -3.45 26.51% | -0.80 76.68% | -0.26 67.70% | -0.49 88.00% | -1.10 124.31% | -0.62 43.84% | -0.83 34.85% | -1.01 21.93% | -0.68 33.08% | |
return on equity | -1.27 - | -3.55 179.94% | -1.20 66.12% | -0.78 35.04% | -0.26 66.29% | -0.46 76.18% | -1.05 126.16% | -0.62 41.24% | -1.11 79.52% | 9.67 973.60% | 1.41 85.38% | |
total debt to capitalization | 0.24 - | 1.12 364.08% | 1.64 47.29% |
All numbers in USD (except ratios and percentages)